[go: up one dir, main page]

IL132279A0 - Prevention of breast cancer with selective estrogen receptor modulators - Google Patents

Prevention of breast cancer with selective estrogen receptor modulators

Info

Publication number
IL132279A0
IL132279A0 IL13227998A IL13227998A IL132279A0 IL 132279 A0 IL132279 A0 IL 132279A0 IL 13227998 A IL13227998 A IL 13227998A IL 13227998 A IL13227998 A IL 13227998A IL 132279 A0 IL132279 A0 IL 132279A0
Authority
IL
Israel
Prior art keywords
prevention
breast cancer
estrogen receptor
receptor modulators
selective estrogen
Prior art date
Application number
IL13227998A
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL132279A0 publication Critical patent/IL132279A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IL13227998A 1997-04-09 1998-04-07 Prevention of breast cancer with selective estrogen receptor modulators IL132279A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4311897P 1997-04-09 1997-04-09
PCT/US1998/006989 WO1998045286A1 (en) 1997-04-09 1998-04-07 Prevention of breast cancer with selective estrogen receptor modulators

Publications (1)

Publication Number Publication Date
IL132279A0 true IL132279A0 (en) 2001-03-19

Family

ID=21925594

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13227998A IL132279A0 (en) 1997-04-09 1998-04-07 Prevention of breast cancer with selective estrogen receptor modulators

Country Status (15)

Country Link
EP (1) EP0975628A4 (en)
JP (1) JP2001518897A (en)
KR (1) KR20010006215A (en)
CN (1) CN1259945A (en)
AU (1) AU6957398A (en)
CA (1) CA2286207A1 (en)
EA (1) EA199900910A1 (en)
HU (1) HUP0001845A2 (en)
ID (1) ID23653A (en)
IL (1) IL132279A0 (en)
NO (1) NO994902L (en)
PL (1) PL336206A1 (en)
TR (1) TR199903244T2 (en)
WO (1) WO1998045286A1 (en)
ZA (1) ZA982818B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653479B1 (en) 1999-07-29 2003-11-25 Eli Lilly And Company Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride
US6610706B1 (en) 1999-07-29 2003-08-26 Eli Lilly And Company Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
NZ585389A (en) 2007-10-16 2011-10-28 Repros Therapeutics Inc Trans-clomiphene for metabolic syndrome
ES2681023T3 (en) 2012-02-29 2018-09-11 Repros Therapeutics Inc. Combination therapy to treat androgen deficit
ES2671516T3 (en) 2013-02-19 2018-06-06 Novartis Ag Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
GB201311888D0 (en) * 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compounds
US11633382B2 (en) 2015-11-10 2023-04-25 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
JP3989569B2 (en) * 1995-02-28 2007-10-10 イーライ リリー アンド カンパニー Benzothiophene compounds, intermediates, compositions and methods
US5731342A (en) * 1996-02-22 1998-03-24 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods

Also Published As

Publication number Publication date
ID23653A (en) 2000-05-11
KR20010006215A (en) 2001-01-26
CN1259945A (en) 2000-07-12
EA199900910A1 (en) 2000-04-24
NO994902L (en) 1999-12-07
PL336206A1 (en) 2000-06-05
WO1998045286A1 (en) 1998-10-15
NO994902D0 (en) 1999-10-08
AU6957398A (en) 1998-10-30
ZA982818B (en) 1999-10-04
CA2286207A1 (en) 1998-10-15
EP0975628A4 (en) 2001-03-21
JP2001518897A (en) 2001-10-16
HUP0001845A2 (en) 2001-06-28
TR199903244T2 (en) 2000-05-22
EP0975628A1 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
EG25606A (en) Glucocorticoid receptor modulators
GB2353527B (en) Adenosine A3 receptor modulators
EP0971588A4 (en) Novel cannabinoid receptor modulators
HUP0204029A3 (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
HUP9602236A3 (en) Mixing bowl
AU1199600A (en) Estrogen receptor ligands
HUP9700636A3 (en) Novel estrogen receptor
GB2318734B (en) Methods of preventing breast cancer
GB9517098D0 (en) Receptor
IL132279A0 (en) Prevention of breast cancer with selective estrogen receptor modulators
GB9703633D0 (en) Cancer therapy
GB9803062D0 (en) Estrogen receptor ligands
GB9928566D0 (en) Human vanilloid receptor-like receptor
GB9913649D0 (en) Estrogen receptor
EP1083909A4 (en) hCEPR RECEPTOR
GB9722884D0 (en) Estrogen receptor
GB9711992D0 (en) Estrogen receptor ligands
GB9717346D0 (en) Estrogen receptor ligands
GB9806032D0 (en) Estrogen receptor
GB9803202D0 (en) Estrogen Receptor Ligands
GB9803061D0 (en) Estrogen receptor ligands
EP1109565A4 (en) Gabab1aa receptor
PL338610A1 (en) Novel non-steroidic ligands of an oestrogen receptor
GB9624800D0 (en) Methods of preventing breast cancer
GB9727347D0 (en) Cancer